Via Nova Therapeutics
PrivateLast Round
Series A
Sep 7, 2021
Total Funding Raised
$20M
Company Overview
Via Nova Therapeutics operates in Healthcare & Life Sciences and is based in Oakland, California. Its latest recorded funding round was a Series A round in September 2021.
Via Nova Therapeutics is a biotechnology company that develops innovative antiviral therapeutics for acute and subacute viral infections, specifically targeting respiratory viruses and their replication mechanisms.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Via Nova Therapeutics Comparables
Compare Via Nova Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Eradivir | 85% | |
| Selva Therapeutics | 81% | |
| Orthogon Therapeutics | 80% |
For institutional investors. Book with your work email.
Via Nova Therapeutics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Via Nova Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Aditum Bio | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 7, 2021
$20M round led by Aditum Bio
For institutional investors. Book with your work email.
Via Nova Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Via Nova Therapeutics's valuation, stock price, and market status.
Is Via Nova Therapeutics a public or private company?
Via Nova Therapeutics is a private company.
What is the current stock price of Via Nova Therapeutics?
Via Nova Therapeutics is a private company, so its shares have no public market price. Caplight tracks Via Nova Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Via Nova Therapeutics worth (valuation)?
Valuation information for Via Nova Therapeutics is not publicly available.
Can I buy Via Nova Therapeutics stock?
Via Nova Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Via Nova Therapeutics's last funding round?
Via Nova Therapeutics's most recent funding round was Series A on September 7, 2021.
Who are the main investors in Via Nova Therapeutics?
Key investors in Via Nova Therapeutics include Aditum Bio.
Will Via Nova Therapeutics IPO soon?
No public IPO plans have been announced for Via Nova Therapeutics.
How can I track Via Nova Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Via Nova Therapeutics's shares on secondary markets.